InsiderClue
← All stocks

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV Net buying
CIK 0001801170 #1978 in the set updated 17 Sep 2026
Bought (120 mo)
$13.72M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$8.82M
$6.56M on a plan · $0.00 straight out of an exercise
Sold at will
$2.26M
7 of 42 sales
Net
+$4.90M
+$11.46M against sales at will

By person

26 insiders · 59 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Palihapitiya Chamath
10% owner
$10.00M (1)
—
+$10.00M
42,239,130
$199.37M
+45.6%
Wai Conrad
CEO, Counterpart Health
—
$3.10M (5) scheduled
−$3.10M
3,625,811
$17.11M
−25.1%
Garipalli Vivek
Director
$3.00M (4)
—
+$3.00M
3,534,120
$16.68M
—
Toy Andrew
Chief Executive Officer
—
$2.37M (3) scheduled
−$2.37M
9,459,316
$44.65M
—
Priest Brady Patrick
CEO of Clover Care Services
—
$1.00M (3)
−$1.00M
2,040,222
$9.63M
+1,341%
Edwards Carladenise Armbrister
Director
—
$951.69K (2)
−$951.69K
285,432
$1.35M
—
Reynoso Jamie L.
CEO, Medicare Advantage
—
$597.63K (20) scheduled
−$597.63K
2,805,367
$13.24M
—
Soares Karen
Chief Legal Officer
—
$536.09K (5) scheduled
−$536.09K
1,607,371
$7.59M
+155.0%
Clinton Chelsea
Director
$252.53K (1)
—
+$252.53K
602,814
$2.85M
—
SHAPIRO LEE
Director
$248.07K (1)
—
+$248.07K
598,622
$2.83M
—
Loengard Anna U
Director
$218.68K (10)
—
+$218.68K
557,066
$2.63M
—
OLDAKOWSKI JOSEPH FRANK
VP OF FINANCE AND CONTROLLER
—
$162.02K (2)
−$162.02K
279,067
$1.32M
−10.3%
THORNTON JOSEPH CLAY
Interim CFO
—
$99.65K (2) scheduled
−$99.65K
1,249,526
$5.90M
+0.9%
Osborne Ian
10% owner
—
—
—
30,500,000
$143.96M
+510.0%
Kuipers Peter J.
Chief Financial Officer
—
—
—
5,758,353
$27.18M
−15.9%
Leffler Scott J.
Chief Financial Officer
—
—
—
4,857,303
$22.93M
+48,473%
CLOVER HEALTH INVESTMENTS, CORP. /DE entity
Chief Technology Officer
—
—
—
3,093,225
$14.60M
+16.6%
Martin Joseph Richards
General Counsel
—
—
—
2,718,857
$12.83M
—
Sharp Aric R
CEO of Value Based Care
—
—
—
2,100,665
$9.92M
—
Singh Prabhdeep
Chief Growth Officer
—
—
—
872,821
$4.12M
—
Kouzoukas Demetrios L.
Director
—
—
—
605,980
$2.86M
—
Robinson William G Jr
Director
—
—
—
597,987
$2.82M
—
Reses Jacqueline D
FORMER DIRECTOR
—
—
—
300,000
$1.42M
—
Tran Thomas L
Director
—
—
—
180,029
$849.74K
+353.6%
Ryans James
FORMER DIRECTOR
—
—
—
100,000
$472.00K
—
Wagner Joseph F.
Chief Financial Officer
—
—
—
25,000
$118.00K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

59
Insider
Date
Role
Action
Shares
Price
Amount
Wai Conrad
15 Sep 2026
CEO, Counterpart Health
Sold on a plan indirect
300,000
$4.72
$1.42M
Reynoso Jamie L.
15 Sep 2026
CEO, Medicare Advantage
Sold on a plan
9,273
$4.78
$44.32K
Soares Karen
15 Sep 2026
Chief Legal Officer
Sold on a plan
6,846
$4.78
$32.72K
OLDAKOWSKI JOSEPH FRANK
14 Sep 2026
VP OF FINANCE AND CONTROLLER
Sell
20,000
$5.16
$103.20K
THORNTON JOSEPH CLAY
17 Aug 2026
Interim CFO
Sold on a plan
17,775
$4.39
$78.03K
Toy Andrew
10 Aug 2026
Chief Executive Officer
Sold on a plan
87,798
$4.65
$408.26K
Soares Karen
20 Jul 2026
Chief Legal Officer
Sold on a plan
51,700
$4.51
$233.17K
Reynoso Jamie L.
17 Jul 2026
CEO, Medicare Advantage
Sold on a plan
4,839
$4.53
$21.92K
THORNTON JOSEPH CLAY
15 Jul 2026
Interim CFO
Sold on a plan
4,630
$4.67
$21.62K
Soares Karen
15 Jul 2026
Chief Legal Officer
Sold on a plan
10,519
$4.67
$49.12K
Reynoso Jamie L.
15 Jul 2026
CEO, Medicare Advantage
Sold on a plan
13,119
$4.67
$61.27K
Wai Conrad
15 Jul 2026
CEO, Counterpart Health
Sold on a plan
24,215
$4.67
$113.08K
Toy Andrew
15 Jul 2026
Chief Executive Officer
Sold on a plan
62,711
$4.67
$292.86K
Reynoso Jamie L.
8 Jul 2026
CEO, Medicare Advantage
Sold on a plan
2,384
$4.68
$11.16K
Reynoso Jamie L.
6 Jul 2026
CEO, Medicare Advantage
Sold on a plan
6,229
$5.26
$32.76K
Toy Andrew
1 Jul 2026
Chief Executive Officer
Sold on a plan
313,476
$5.32
$1.67M
Reynoso Jamie L.
17 Jun 2026
CEO, Medicare Advantage
Sold on a plan
2,360
$4.78
$11.28K
OLDAKOWSKI JOSEPH FRANK
16 Jun 2026
VP OF FINANCE AND CONTROLLER
Sold on a plan
12,102
$4.86
$58.82K
Reynoso Jamie L.
15 Jun 2026
CEO, Medicare Advantage
Sold on a plan
6,350
$4.61
$29.27K
Soares Karen
15 Jun 2026
Chief Legal Officer
Sold on a plan
4,681
$4.61
$21.58K
Reynoso Jamie L.
11 Jun 2026
CEO, Medicare Advantage
Sold on a plan
7,289
$4.91
$35.79K
Wai Conrad
28 May 2026
CEO, Counterpart Health
Sold on a plan indirect
220,426
$3.99
$879.50K
Edwards Carladenise Armbrister
18 May 2026
Director
Sell
67,160
$3.42
$229.69K
Priest Brady Patrick
13 May 2026
CEO of Clover Care Services
Sell
98,039
$3.52
$345.10K
Reynoso Jamie L.
18 Mar 2026
CEO, Medicare Advantage
Sold on a plan
5,833
$1.91
$11.14K
Priest Brady Patrick
4 Mar 2026
CEO of Home Care
Sell
175,000
$2.17
$379.75K
Reynoso Jamie L.
20 Jan 2026
CEO, Medicare Advantage
Sold on a plan
4,597
$2.58
$11.86K
Reynoso Jamie L.
7 Jan 2026
CEO, Medicare Advantage
Sold on a plan
2,102
$2.53
$5.32K
Reynoso Jamie L.
18 Dec 2025
CEO, Medicare Advantage
Sold on a plan
4,913
$2.61
$12.82K
Reynoso Jamie L.
4 Nov 2025
CEO, Medicare Advantage
Sold on a plan
30,385
$3.58
$108.78K
Reynoso Jamie L.
17 Oct 2025
CEO, Medicare Advantage
Sold on a plan
16,514
$2.69
$44.42K
Reynoso Jamie L.
7 Oct 2025
CEO, Medicare Advantage
Sold on a plan
2,012
$2.65
$5.33K
Reynoso Jamie L.
17 Sep 2025
CEO, Medicare Advantage
Sold on a plan
4,914
$3.09
$15.18K
Loengard Anna U
13 Aug 2025
Director
Buy indirect
14,500
$2.59
$37.56K
Loengard Anna U
13 Aug 2025
Director
Buy indirect
12,000
$2.60
$31.20K
Garipalli Vivek
8 Aug 2025
Director
Buy
31,980
$2.17
$69.40K
Garipalli Vivek
7 Aug 2025
Director
Buy
415,000
$2.24
$929.60K
Reynoso Jamie L.
4 Aug 2025
CEO, Medicare Advantage
Sold on a plan
6,823
$2.89
$19.72K
Wai Conrad
23 Jul 2025
CEO, Counterpart Health
Sold on a plan indirect
91,197
$3.32
$302.77K
Wai Conrad
22 Jul 2025
CEO, Counterpart Health
Sold on a plan indirect
118,600
$3.29
$390.19K
Reynoso Jamie L.
7 Jul 2025
CEO, Medicare Advantage
Sold on a plan
2,012
$2.85
$5.73K
Reynoso Jamie L.
3 Jul 2025
CEO, Medicare Advantage
Sold on a plan
19,789
$2.58
$51.06K
Reynoso Jamie L.
17 Jun 2025
CEO, Medicare Advantage
Sold on a plan
20,450
$2.86
$58.49K
Edwards Carladenise Armbrister
7 Mar 2025
Director
Sell
200,000
$3.61
$722.00K
Soares Karen
6 Mar 2025
General Counsel & Secretary
Sell
52,500
$3.80
$199.50K
Priest Brady Patrick
6 Mar 2025
CEO of Home Care
Sell
75,000
$3.68
$276.00K
Garipalli Vivek
9 Aug 2024
Director
Buy
531,700
$1.88
$999.60K
Garipalli Vivek
17 Jun 2024
Director
Buy
877,567
$1.14
$1.00M
Loengard Anna U
17 May 2024
Director
Buy indirect
10,000
$0.93
$9.30K
Loengard Anna U
16 May 2024
Director
Buy indirect
1,485
$0.94
$1.40K
Loengard Anna U
16 May 2024
Director
Buy indirect
15,600
$0.96
$14.98K
Loengard Anna U
14 Mar 2024
Director
Buy indirect
13,625
$0.73
$9.95K
Loengard Anna U
14 Mar 2024
Director
Buy
137,000
$0.73
$100.01K
Loengard Anna U
6 Sep 2023
Director
Buy indirect
500
$1.30
$650.00
Loengard Anna U
6 Sep 2023
Director
Buy indirect
500
$1.30
$650.00
Loengard Anna U
6 Sep 2023
Director
Buy indirect
10,000
$1.30
$13.00K
SHAPIRO LEE
11 Mar 2022
Director
Buy
80,000
$3.10
$248.07K
Clinton Chelsea
3 Mar 2022
Director
Buy
100,000
$2.53
$252.53K
Palihapitiya Chamath
22 Nov 2021
10% owner
Buy indirect
1,739,130
$5.75
$10.00M

What was left out

Form 4 filings counted 289
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 35
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 152,393,713
History held since 11 Jan 2021